Toxicological and pharmacological evaluation, antioxidant, ADMET and molecular modeling of selected racemic chromenotacrines {11-amino-12-aryl-8,9,10,12-tetrahydro-7H-chromeno[2,3-b]quinolin-3-ols} for the potential prevention and treatment of Alzheimer's

Chromenotacrine 11-amino-12-(3,4,5-trimethoxyphenyl)-8,9,10,12-tetrahydro-7H-chromeno[2,3-b]quinolin-3-ol(CT6) is a non-toxic, antioxidant, neuroprotective, potent, selective and non-competitive EeAChE inhibitor.